Abstract:Abstract In recent years, a large amount of evidence has given a central role to translational control in diseases such as cancer, tissue hypertrophy and neurodegeneration. Its deregulation can directly modulate cell cycling, transformation and survival response. The aim of this review is to describe the interaction between Raf activation and the main characters of the translational machinery, such as the elongation factor 1A (eEF1A), which has been recognized in recent years as one of the most interesting putative oncogenes. A particular emphasis is given to an intriguing non-canonical role that eEF1A can play in the relationship between the Ras→Raf-1→MEK1→ERK-1/2 and PI3K→Akt signaling pathways. Recently, our group has described a C-Raf kinase-mediated phosphorylation of eEF1A triggered by a survival pathway induced upon interferon alpha (IFNα) treatment in the human epidermoid cancer cell line (H1355). This phosphorylation seems to be the center of the survival pathway that counteracts the well-known pro-apoptotic function of IFNα. Furthermore, we have identified two new phosphorylation sites on eEF1A (Ser21 and Thr88) that are substrates for Raf kinases in vitro and, likely, in vivo as well. These residues seem to have a significant functional role in the control of cellular processes, such as cell proliferation and survival. In fact, overexpression of eEF1A2 in gemcitabine-treated cancer cells caused the upregulation of phosphoAkt and an increase in cell viability, thereby suggesting that eEF1A2 could exert its oncogenic behavior by participating in the regulation of PI3K pathway.

The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective

Arf proteins in cancer cell migration

Control of cell signaling by Arf GTPases and their regulators: Focus on links to cancer and other GTPase families

Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis

Roles of Arf6 in cancer cell invasion, metastasis and proliferation

RAL GTPases: Biology and Potential As Therapeutic Targets in Cancer

ARF GTPases and their GEFs and GAPs: concepts and challenges

The Mechanisms Of Diras Family Members In Role Of Tumor Suppressor

Membrane trafficking alterations in breast cancer progression

ADP-Ribosylation Factor 6 Pathway Acts as a Key Executor of Mesenchymal Tumor Plasticity

Suppression of Breast Cancer Metastasis Through the Inactivation of ADP-ribosylation Factor 1.

Abrogation of ARF6 Promotes RSL3-induced Ferroptosis and Mitigates Gemcitabine Resistance in Pancreatic Cancer Cells.

The role of CRAF in cancer progression: from molecular mechanisms to precision therapies

ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer

Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis

RGS Proteins and Their Roles in Cancer: Friend or Foe?

The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?

Biological Significance and Targeting of the FGFR Axis in Cancer

Raf kinases in signal transduction and interaction with translation machinery

Targeting Rho GTPase Signaling Networks in Cancer